What Is the Best Risk-Reducing Decision for Breast Cancer Patients With BRCA1/2 Mutation?

Archives of Breast Cancer
doi 10.32768/abc.201854148-149
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Archives of Breast Cancer

Related search

Lurbinectedin Is Active in Patients With BRCA1/2 Mutant Breast Cancer

Cancer Discovery
Oncology
2018English

Body Weight and Risk of Breast Cancer in BRCA1/2 Mutation Carriers

Breast Cancer Research and Treatment
Cancer ResearchOncology
2010English

Physical Activity and the Risk of Breast Cancer in BRCA1/2 Mutation Carriers

Breast Cancer Research and Treatment
Cancer ResearchOncology
2009English

Performance of BRCA1/ 2 Mutation Prediction Models in Male Breast Cancer Patients

Clinical Genetics
Genetics
2017English

RASSF1A Polymorphism A133S Is Associated With Early Onset Breast Cancer in BRCA1/2 Mutation Carriers

Cancer Research
Cancer ResearchOncology
2008English

Seventeen Years After BRCA1: What Is the BRCA Mutation Status of the Breast Cancer Patients in Africa? – A Systematic Review

SpringerPlus
Multidisciplinary
2012English

A Patient Decision Aid for Risk-Reducing Surgery in Premenopausal BRCA1/2 Mutation Carriers: Development Process and Pilot Testing

Health Expectations
EnvironmentalPublic HealthOccupational Health
2017English

BRCA1 (185delAG) Mutation Among Egyptian Breast Cancer Female Patients

Journal of High Institute of Public Health
2008English

Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality

JAMA - Journal of the American Medical Association
Medicine
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy